VirTrial, a portfolio company of Kinderhook Industries, LLC, has acquired SnapMD, a provider of telemedicine tools and services that improve patient engagement. The acquisition bolsters VirTrial's capabilities with access to SnapMD's telemedicine platform and technical expertise. In addition, the relationship enables integration of additional features and capabilities into VirTrial's Virtual Care Management (VCM) platform to further establish VirTrial as the dominant global decentralized clinical trial (DCT) solution in the market.

The acquisition supports VirTrial's goal of making hybrid decentralized clinical trials seamless for sponsors, sites, and patients. The VirTrial platform works with any device (Apple, Android, tablet and/or computer) and can be used by any site. Continuing that focus on flexibility and ease of use, new enhancements available via SnapMD technology will improve functionality and further simplify user experience.

Our acquisition of SnapMD enables us to better implement our vision of making clinical trials easier for everyone involved from sponsors to sites and patients. By offering a simplified, straight-forward user experience and the ability for sponsors to include multiple countries with extensive features, VirTrial continues to set the bar in decentralized clinical trial platforms, said Mark Hanley, CEO of VirTrial.

SnapMD's VCM solution is used by providers nationwide to engage patients via a secure, HIPAA-compliant, cloud-based software platform. The company will operate as a subsidiary of VirTrial and will continue to provide its market-leading telemedicine solution across the healthcare space.

We are extremely thrilled to join the VirTrial team and drive the evolution of telemedicine platforms in the clinical research industry, said David Skibinski, CEO of SnapMD. This transaction will enable SnapMD to further its commitment to improve access to care, regardless of setting, through an industry-best telemedicine solution and unmatched breadth of services.

About VirTrial

VirTrial is a telemedicine company providing a stable, long-standing virtual care management (VCM) platform to transform the clinical trial industry. The platform combines video, text, and email allowing pharmaceutical companies and CROs to create patient centric Decentralized Clinical Trials (DCTs) by replacing some study visits with virtual visits. The vision is for 25-50% of visits to be conducted virtually creating a hybrid model. This...

To continue reading